IRADIMED CORP - Common Stock (IRMD)

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
6,101,541
Share change
-60,769
Total reported value
$270,676,799
Price per share
$44.37
Number of holders
113
Value change
-$3,589,692
Number of buys
62
Number of sells
46

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q3 2023

As of 30 Sep 2023, IRADIMED CORP - Common Stock (IRMD) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,101,541 shares. The largest 10 holders included Nine Ten Capital Management LLC, Soleus Capital Management, L.P., BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, RK Capital Management, LLC, Bares Capital Management, Inc., Ranger Investment Management, L.P., DIMENSIONAL FUND ADVISORS LP, and Russell Investments Group, Ltd.. This page lists 113 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.